<DOC>
	<DOCNO>NCT00238550</DOCNO>
	<brief_summary>The study design investigate benefit add CBME exist treatment regime management painful neuropathy . Hypothesis : 1 . The addition CBME exist treatment regime result significant improvement primary secondary outcome measure . 2 . The side effect profile tolerability CBME minimal comparable placebo .</brief_summary>
	<brief_title>Study CBME Relief Painful Diabetic Neuropathy</brief_title>
	<detailed_description>1 . To investigate benefit add CBME exist treatment regime management painful neuropathy . 2 . To study tolerability side effect profile CBME . 3 . To study effect CBME treatment vibration perception threshold ( VPT ) nerve conduction study parameter . 4 . To evaluate effect CBME central nervous system deep nucleus use MR Spectroscopy .</detailed_description>
	<mesh_term>Peripheral Nervous System Diseases</mesh_term>
	<mesh_term>Pain</mesh_term>
	<mesh_term>Diabetic Neuropathies</mesh_term>
	<criteria>Diagnoses diabetes base criterion set World Health Organisation . Subjects must 18 year age . Female subject child bear potential male subject whose partner child bear potential must willing ensure partner use effective contraception study three month thereafter . Written consent obtain . Volunteers must symptoms consistent painful neuropathy least six month eligible recruitment ( NTSS 6 score great 4 less 16 ) . Subjects symptoms painful neuropathy persist despite adequate trial tricyclic antidepressant ( TCA ) . Stable dose current treatment neuropathy least 3 month prior entry study . Able ( investigator opinion ) willing comply study requirement . Willing allow GP consultant , appropriate , notified participation study . Willing allow name notify Home Office GW Pharma participation study . Previous cerebrovascular event neurological disorder . unstable glycaemic control six month . History cardiovascular disorder . History schizophrenia psychiatric illnesses depression associate painful diabetic neuropathy History epilepsy . Serious illness preclude gather potentially impact primary secondary outcome measure example major organ failure , neoplasia coeliac disease . Unwilling stop driving operate dangerous machinery four hour dose study medication experience side effect . Anticipated foreign travel within first 15 week trial . Participants research study currently within previous three month . Current past history substance abuse . Previous current history consume 20 unit alcohol week . Neuropathy due aetiology . Known suspect hypersensitivity cannabinoids excipients study medication . Known suspect adverse reaction cannabinoids . Pregnancy lactate mother plan pregnancy course study . Not use adequate contraception Current use fentanyl Significant renal hepatic impairment show medical history indicate clinical laboratory result sample take baseline . Scheduled elective surgery procedure require general anaesthesia study . Regular levodopa therapy within 7 day study entry . Severe cognitive impairment patient unable provide inform consent . Donation blood study Other problem likely make participation difficult discretion Treatment Physician</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>October 2005</verification_date>
	<keyword>Diabetes</keyword>
	<keyword>Pain</keyword>
	<keyword>Peripheral neuropathy</keyword>
</DOC>